A detailed history of West Paces Advisors Inc. transactions in Biogen Inc. stock. As of the latest transaction made, West Paces Advisors Inc. holds 70 shares of BIIB stock, worth $12,165. This represents 0.0% of its overall portfolio holdings.

Number of Shares
70
Previous 70 -0.0%
Holding current value
$12,165
Previous $16.2 Million 16.38%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

SELL
$212.02 - $267.71 $212 - $267
-1 Reduced 1.41%
70 $15.1 Million
Q4 2023

Jan 30, 2024

BUY
$222.59 - $267.94 $222 - $267
1 Added 1.43%
71 $18.4 Million
Q4 2022

Dec 18, 2023

BUY
$252.44 - $306.72 $17,670 - $21,470
70 New
70 $19.4 Million
Q4 2021

Dec 19, 2023

SELL
$223.92 - $287.77 $4,478 - $5,755
-20 Reduced 22.22%
70 $16.8 Million
Q3 2021

Dec 19, 2023

SELL
$282.99 - $369.05 $14,149 - $18,452
-50 Reduced 35.71%
90 $25.5 Million
Q1 2021

Dec 19, 2023

BUY
$242.95 - $284.63 $12,147 - $14,231
50 Added 55.56%
140 $39.2 Million
Q2 2020

Dec 19, 2023

BUY
$258.66 - $342.55 $5,173 - $6,851
20 Added 28.57%
90 $24.1 Million
Q1 2020

Dec 20, 2023

SELL
$268.85 - $341.04 $10,754 - $13,641
-40 Reduced 30.77%
90 $28.5 Million
Q4 2019

Dec 21, 2023

SELL
$220.06 - $304.07 $220 - $304
-1 Reduced 0.88%
112 $33.2 Million
Q3 2019

Dec 21, 2023

SELL
$217.44 - $243.88 $2,826 - $3,170
-13 Reduced 10.32%
113 $26.3 Million
Q2 2019

Dec 21, 2023

SELL
$219.29 - $241.72 $877 - $966
-4 Reduced 3.08%
126 $29.5 Million
Q3 2018

Dec 20, 2023

BUY
$293.51 - $383.83 $17,610 - $23,029
60 Added 85.71%
130 $45.9 Million
Q2 2018

Dec 21, 2023

BUY
$257.52 - $306.91 $1,030 - $1,227
4 Added 3.17%
130 $37.7 Million
Q4 2016

Dec 21, 2023

BUY
N/A
56
126 $35.7 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track West Paces Advisors Inc. Portfolio

Follow West Paces Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Paces Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on West Paces Advisors Inc. with notifications on news.